Eli Lilly to acquire Seattle-area biotech in $1.5 billion bet on next-generation shingles vaccine
This story is reported by GeekWire. Read what other outlets are saying below, then open the original report for full details.
This story is reported by GeekWire. Read what other outlets are saying below, then open the original report for full details.